I agree and will not give blind forgiveness for his specific and self-imposed deadline without an explanation. If explained or if/once a deal is done I will reconsider. I was and am still routing for him to silence his critics, but if a license deal is not completed and announced this week, this is entirely on him and his criticism deserved until these issues are resolved.
I'm still looking forward to the many upcoming announcements and huge believer in leronlimab being a game changer in HIV and cancer (and possibly many more indications), but am keeping my expectations tempered until I read the PR going forward.
(3)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.